Literature DB >> 24449343

Proteomic analysis of human substantia nigra identifies novel candidates involved in Parkinson's disease pathogenesis.

Virginie Licker1, Natacha Turck, Enikö Kövari, Karim Burkhardt, Mélanie Côte, Maria Surini-Demiri, Johannes A Lobrinus, Jean-Charles Sanchez, Pierre R Burkhard.   

Abstract

Parkinson's disease (PD) pathology spreads throughout the brain following a region-specific process predominantly affecting the substantia nigra (SN) pars compacta. SN exhibits a progressive loss of dopaminergic neurons responsible for the major cardinal motor symptoms, along with the occurrence of Lewy bodies in the surviving neurons. To gain new insights into the underlying pathogenic mechanisms in PD, we studied postmortem nigral tissues dissected from pathologically confirmed PD cases (n = 5) and neurologically intact controls (n = 8). Using a high-throughput shotgun proteomic strategy, we simultaneously identified 1795 proteins with concomitant quantitative data. To date, this represents the most extensive catalog of nigral proteins. Of them, 204 proteins displayed significant expression level changes in PD patients versus controls. These were involved in novel or known pathogenic processes including mitochondrial dysfunction, oxidative stress, or cytoskeleton impairment. We further characterized four candidates that might be relevant to PD pathogenesis. We confirmed the differential expression of ferritin-L and seipin by Western blot and demonstrated the neuronal localization of gamma glutamyl hydrolase and nebulette by immunohistochemistry. Our preliminary findings suggest a role for nebulette overexpression in PD neurodegeneration, through mechanisms that may involve cytoskeleton dynamics disruption. All MS data have been deposited in the ProteomeXchange with identifier PXD000427 (http://proteomecentral.proteomexchange.org/dataset/PXD000427).
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Biomedicine; Nebulette; Parkinson's disease; Postmortem tissue; Substantia nigra

Mesh:

Substances:

Year:  2014        PMID: 24449343     DOI: 10.1002/pmic.201300342

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  37 in total

1.  Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerization.

Authors:  Judith Eschbach; Björn von Einem; Kathrin Müller; Hanna Bayer; Annika Scheffold; Bradley E Morrison; K Lenhard Rudolph; Dietmar R Thal; Anke Witting; Patrick Weydt; Markus Otto; Michael Fauler; Birgit Liss; Pamela J McLean; Albert R La Spada; Albert C Ludolph; Jochen H Weishaupt; Karin M Danzer
Journal:  Ann Neurol       Date:  2014-12-19       Impact factor: 10.422

Review 2.  Parkinson's disease: proteinopathy or lipidopathy?

Authors:  Saranna Fanning; Dennis Selkoe; Ulf Dettmer
Journal:  NPJ Parkinsons Dis       Date:  2020-01-03

3.  Characterization of Detergent Insoluble Proteome in Chronic Traumatic Encephalopathy.

Authors:  Jonathan D Cherry; Ahmad Zeineddin; Eric B Dammer; James A Webster; Duc Duong; Nicholas T Seyfried; Allan I Levey; Victor E Alvarez; Bertrand R Huber; Thor D Stein; Patrick T Kiernan; Ann C McKee; James J Lah; Chadwick M Hales
Journal:  J Neuropathol Exp Neurol       Date:  2018-01-01       Impact factor: 3.685

4.  Large-Scale, Ion-Current-Based Proteomic Investigation of the Rat Striatal Proteome in a Model of Short- and Long-Term Cocaine Withdrawal.

Authors:  Shichen Shen; Xiaosheng Jiang; Jun Li; Robert M Straubinger; Mauricio Suarez; Chengjian Tu; Xiaotao Duan; Alexis C Thompson; Jun Qu
Journal:  J Proteome Res       Date:  2016-04-11       Impact factor: 4.466

5.  Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brain.

Authors:  Sian Genoud; Blaine R Roberts; Adam P Gunn; Glenda M Halliday; Simon J G Lewis; Helen J Ball; Dominic J Hare; Kay L Double
Journal:  Metallomics       Date:  2017-10-18       Impact factor: 4.526

6.  Network Analysis Identifies Disease-Specific Pathways for Parkinson's Disease.

Authors:  Chiara Monti; Ilaria Colugnat; Leonardo Lopiano; Adriano Chiò; Tiziana Alberio
Journal:  Mol Neurobiol       Date:  2016-12-21       Impact factor: 5.590

Review 7.  Proteomics in Human Parkinson's Disease: Present Scenario and Future Directions.

Authors:  Anubhuti Dixit; Rachna Mehta; Abhishek Kumar Singh
Journal:  Cell Mol Neurobiol       Date:  2019-06-12       Impact factor: 5.046

Review 8.  Reverse engineering Lewy bodies: how far have we come and how far can we go?

Authors:  Mohamed Bilal Fares; Somanath Jagannath; Hilal A Lashuel
Journal:  Nat Rev Neurosci       Date:  2021-01-11       Impact factor: 34.870

Review 9.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

10.  Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease.

Authors:  Fabio A Zucca; Renzo Vanna; Francesca A Cupaioli; Chiara Bellei; Antonella De Palma; Dario Di Silvestre; Pierluigi Mauri; Sara Grassi; Alessandro Prinetti; Luigi Casella; David Sulzer; Luigi Zecca
Journal:  NPJ Parkinsons Dis       Date:  2018-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.